Imlifidase

Name: Imlifidase in Kidney transplantation in highly sensitized patients: Clinical presentation - signs and symptoms
Published: 2026-09-14T15:39:06-04:00

Kidney transplantation in highly sensitized patients

Manufacturer: Hansa Biopharma
Regulatory submission: BLA submitted December 2025
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description

Clinical presentation - signs and symptoms

2 evidence topics · 1 source

Fluid retention: manifestations of kidney failure

“have swelling, usually in your legs, feet, or ankles” (opens the source at this quote in a new tab)

Fatigue and sleep disturbance: manifestations of kidney failure

“feel tired during the day and have sleep problems at night” (opens the source at this quote in a new tab)